Novartis and Microsoft have come together to capitalize on advanced Microsoft AI technology combined with Novartis’ deep life sciences-based drug discovery and development expertise to find new ways to address the challenges underlying every phase of drug...
Microsoft Corp and UK Drug drugmaker AstraZeneca Plc are building a health-tech incubator in Paris to help build an ecosystem of innovative problem solvers leveraging the Microsoft Azure cloud network. Bloomberg reports that the “AI Factory for Health” represents an...
Pin It on Pinterest
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site you consent to our use of cookies.Ok
